|
|
snrna metabolic process
|
GO:0016073 |
15 |
1.000
|
|
|
|
nuclear transcribed mrna catabolic process exonucleolytic
|
GO:0000291 |
7 |
1.000
|
|
|
|
rna phosphodiester bond hydrolysis exonucleolytic
|
GO:0090503 |
14 |
1.000
|
|
|
|
maturation of 5 8s rrna
|
GO:0000460 |
8 |
0.991
|
|
|
|
rrna catabolic process
|
GO:0016075 |
6 |
0.987
|
|
|
|
nuclear rna surveillance
|
GO:0071027 |
4 |
0.986
|
|
|
|
nuclear polyadenylation dependent ncrna catabolic process
|
GO:0071046 |
2 |
0.986
|
|
|
|
trna catabolic process
|
GO:0016078 |
1 |
0.985
|
|
|
|
rna phosphodiester bond hydrolysis
|
GO:0090501 |
35 |
0.984
|
|
|
|
ncrna metabolic process
|
GO:0034660 |
108 |
0.982
|
|
|
|
exonucleolytic nuclear transcribed mrna catabolic process involved in deadenylation dependent decay
|
GO:0043928 |
6 |
0.971
|
|
|
|
ncrna catabolic process
|
GO:0034661 |
14 |
0.969
|
|
|
|
nuclear ncrna surveillance
|
GO:0071029 |
2 |
0.969
|
|
|
|
polyadenylation dependent rna catabolic process
|
GO:0043633 |
3 |
0.956
|
|
|
|
trna metabolic process
|
GO:0006399 |
35 |
0.941
|
|
|
|
nuclear polyadenylation dependent rrna catabolic process
|
GO:0071035 |
2 |
0.941
|
|
|
|
nuclear transcribed mrna catabolic process
|
GO:0000956 |
48 |
0.940
|
|
|
|
mrna catabolic process
|
GO:0006402 |
56 |
0.928
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.924
|
|
|
|
ncrna processing
|
GO:0034470 |
83 |
0.911
|
|
|
|
rrna metabolic process
|
GO:0016072 |
40 |
0.885
|
|
|
|
ncrna 3 end processing
|
GO:0043628 |
4 |
0.877
|
|
|
|
snrna processing
|
GO:0016180 |
14 |
0.859
|
|
|
|
maturation of 5 8s rrna from tricistronic rrna transcript ssu rrna 5 8s rrna lsu rrna
|
GO:0000466 |
2 |
0.846
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
1 |
0.843
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
102 |
0.821
|
|
|
|
polyadenylation dependent ncrna catabolic process
|
GO:0043634 |
2 |
0.807
|
|
|
|
rna 3 end processing
|
GO:0031123 |
35 |
0.806
|
|
|
|
rna catabolic process
|
GO:0006401 |
71 |
0.795
|
|
|
|
dna deamination
|
GO:0045006 |
9 |
0.719
|
|
|
|
rna surveillance
|
GO:0071025 |
5 |
0.676
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.648
|
|
|
|
nuclear mrna surveillance
|
GO:0071028 |
4 |
0.636
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.635
|
|
|
|
ribonucleoprotein complex biogenesis
|
GO:0022613 |
116 |
0.501
|
|
|
|
ribosome biogenesis
|
GO:0042254 |
48 |
0.481
|
|
|
|
rrna processing
|
GO:0006364 |
35 |
0.470
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.465
|
|
|
|
mrna metabolic process
|
GO:0016071 |
175 |
0.455
|
|
|
|
dna modification
|
GO:0006304 |
27 |
0.291
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.278
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.216
|
|
|
|
nuclear transcribed mrna catabolic process nonsense mediated decay
|
GO:0000184 |
23 |
0.185
|
|
|
|
histone mrna metabolic process
|
GO:0008334 |
13 |
0.185
|
|
|
|
dna catabolic process endonucleolytic
|
GO:0000737 |
37 |
0.149
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.144
|
|
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.135
|
|
|
|
growth
|
GO:0040007 |
202 |
0.121
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.106
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.105
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
48 |
0.093
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.091
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.077
|
|
|
|
cut metabolic process
|
GO:0071043 |
3 |
0.076
|
Human |
|
|
defense response
|
GO:0006952 |
315 |
0.067
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.063
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.062
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.056
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.055
|
|
|
|
snorna metabolic process
|
GO:0016074 |
1 |
0.051
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.051
|
|
|
|
spinal cord development
|
GO:0021510 |
4 |
0.050
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.048
|
|
|
|
response to virus
|
GO:0009615 |
126 |
0.048
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.044
|
|
|
|
positive regulation of growth
|
GO:0045927 |
58 |
0.044
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.044
|
|
|
|
defense response to virus
|
GO:0051607 |
71 |
0.044
|
|
|
|
cellular component disassembly
|
GO:0022411 |
92 |
0.043
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.043
|
Human |
|
|
polyadenylation dependent mrna catabolic process
|
GO:0071047 |
1 |
0.042
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.039
|
|
|
|
snrna 3 end processing
|
GO:0034472 |
1 |
0.038
|
|
|
|
system process
|
GO:0003008 |
349 |
0.034
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.034
|
Human |
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.032
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.030
|
Human |
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.029
|
|
|
|
neuronal action potential
|
GO:0019228 |
9 |
0.028
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.028
|
|
|
|
cut catabolic process
|
GO:0071034 |
3 |
0.028
|
Human |
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.027
|
|
|
|
nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:0000288 |
14 |
0.026
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.026
|
Human |
|
|
head development
|
GO:0060322 |
108 |
0.025
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.025
|
|
|
|
dna catabolic process
|
GO:0006308 |
49 |
0.025
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.024
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.023
|
Human |
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.023
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.023
|
Human |
|
|
rna interference
|
GO:0016246 |
4 |
0.022
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.022
|
|
|
|
nuclear polyadenylation dependent mrna catabolic process
|
GO:0071042 |
1 |
0.022
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.022
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.022
|
Human |
|
|
organic acid catabolic process
|
GO:0016054 |
71 |
0.022
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.021
|
|
|
|
execution phase of apoptosis
|
GO:0097194 |
32 |
0.021
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.020
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
100 |
0.020
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.020
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.020
|
Human |
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.020
|
Human |
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.020
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.020
|
Human |
|
|
positive regulation of dna metabolic process
|
GO:0051054 |
73 |
0.020
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.019
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.019
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
1 |
0.019
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.019
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.019
|
|
|
|
immune effector process
|
GO:0002252 |
159 |
0.018
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.018
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.018
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.018
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.017
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.016
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.016
|
|
|
|
defense response to bacterium
|
GO:0042742 |
63 |
0.016
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
40 |
0.016
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.016
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.015
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.015
|
Human |
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.015
|
Human |
|
|
axon ensheathment
|
GO:0008366 |
6 |
0.015
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.015
|
Human |
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.015
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.015
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.014
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.014
|
|
|
|
translation
|
GO:0006412 |
132 |
0.014
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.014
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.014
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.014
|
|
|
|
action potential
|
GO:0001508 |
34 |
0.014
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.014
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.014
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.014
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.014
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.014
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.013
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
79 |
0.013
|
|
|
|
rna splicing
|
GO:0008380 |
131 |
0.013
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.013
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.013
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.013
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.013
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.013
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.013
|
|
|
|
meiotic chromosome segregation
|
GO:0045132 |
4 |
0.013
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.013
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.013
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.013
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.013
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
84 |
0.012
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.012
|
|
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.012
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.012
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
11 |
0.012
|
|
|
|
protein alkylation
|
GO:0008213 |
74 |
0.012
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.012
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
67 |
0.012
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.012
|
Human |
|
|
protein targeting
|
GO:0006605 |
187 |
0.012
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.012
|
|
|
|
histone methylation
|
GO:0016571 |
60 |
0.012
|
|
|
|
trna processing
|
GO:0008033 |
23 |
0.012
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
87 |
0.012
|
|
|
|
tissue homeostasis
|
GO:0001894 |
63 |
0.012
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.012
|
|
|
|
apoptotic dna fragmentation
|
GO:0006309 |
6 |
0.011
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
40 |
0.011
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.011
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.011
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.011
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.011
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.011
|
Human |
|
|
cellular component disassembly involved in execution phase of apoptosis
|
GO:0006921 |
13 |
0.011
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.011
|
Human |
|
|
mitochondrial respiratory chain complex assembly
|
GO:0033108 |
23 |
0.011
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.011
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.011
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.011
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.011
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.011
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.011
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.011
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.010
|
Human |
|
|
secretion by cell
|
GO:0032940 |
226 |
0.010
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.010
|
Human |
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.010
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.010
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
12 |
0.010
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.010
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.010
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.010
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.010
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.010
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.010
|
|